Ultragenyx Pharmaceutical is Drug Discovery in United States that focus on Ultragenyx Pharmaceutical Inc business. Founded in 2010. They cover business area such as Ultragenyx Pharmaceutical Inc, acquire, novel product, genetic disease, Crysvita, Mepsevii, x-link hypophosphatemia, (xlh, adult and pediatric patient, pediatric and adult patient, Mucopolysaccharidosis VII.
2010
( 14 years old in 2024 )
Ultragenyx Pharmaceutical Inc
-
60 Leveroni Court
Novato, CA 94949
United States
Private
Ultragenyx Pharmaceutical Incacquirenovel productgenetic diseaseCrysvitaMepseviix-link hypophosphatemia(xlhadult and pediatric patientpediatric and adult patientMucopolysaccharidosis VII
* We use standard office opening hours in near Ultragenyx Pharmaceutical's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ultragenyx Pharmaceutical is Drug Discovery business from United States that founded in 2010 (14 years old in 2024), Ultragenyx Pharmaceutical business is focusing on Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical headquarter office and corporate office address is located in 60 Leveroni Court Novato, CA 94949 United States.
Ultragenyx Pharmaceutical was founded in United States.
In 2024, Ultragenyx Pharmaceutical is currently focus on Ultragenyx Pharmaceutical Inc sector.
Above is snippet of Google Trends for "Ultragenyx Pharmaceutical Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ultragenyx Pharmaceutical, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
